መነሻ › Metastatic Cancer › ሚሺጋን › Detroit
በDetroit፣ MI ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች
ለMetastatic Cancer የሚደረጉ 24 ጥናቶች በDetroit እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Henry Ford Cancer- Detroit, Detroit
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Detroit
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Henry Ford Cancer Institute, Detroit
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Karmanos Cancer Institute, Detroit
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Karmanos Cancer Institute, Detroit
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Clinical Study Site, Detroit
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Henry Ford Cancer Institute/Henry Ford Health System, Detroit
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Crinetics Study Site, Detroit
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Henry Ford Hospital, Detroit
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Investigative Site #120, Detroit
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Henry Ford Health System, Detroit
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Henry Ford Hospital, Detroit
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
ተሳታዮችን በመፈለግ ላይ
- Henry Ford Hospital, Detroit
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Henry Ford Cancer Institute, Detroit
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Henry Ford Health System, Detroit
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Henry Ford Cancer Center, Detroit
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Henry Ford Cancer Institute, Detroit
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Karmanos Cancer Institute, Detroit
A Beta-only IL-2 ImmunoTherapY Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Karmanos Cancer Institute, Detroit
በሌሎች ከተሞች ለMetastatic Cancer የሚደረጉ ጥናቶች
- Houston, TX104 ጥናቶች
- New York City, NY93 ጥናቶች
- Nashville, TN70 ጥናቶች
- Boston, MA63 ጥናቶች
- Los Angeles, CA57 ጥናቶች
- St. Louis, MO54 ጥናቶች
- Arlington, VA53 ጥናቶች
- Philadelphia, PA46 ጥናቶች
- Chicago, IL45 ጥናቶች
- San Antonio, TX44 ጥናቶች
- Washington, DC43 ጥናቶች
- Dallas, TX42 ጥናቶች
በDetroit ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር44 ጥናቶች
- የጡንቻ ካንሰር33 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)29 ጥናቶች
- የኮሎሬክታል ካንሰር26 ጥናቶች
- የእንቁላል ካንሰር26 ጥናቶች
- የፕሮስቴት ካንሰር22 ጥናቶች
- የኤንዶሜትሪየም ካንሰር21 ጥናቶች
- የሳንባ ካንሰር20 ጥናቶች
- Multiple Myeloma19 ጥናቶች
- የሆድ ካንሰር16 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ15 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ14 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።